Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Cefixime (50mg) + Ofloxacin (50mg) Dry Syrup
Therapeutic Category
Antibacterials, Antibiotic, Gastroenterology, Pediatrics, Pulmonary, Respiratory
Dosage Form
Dry Syrup
Packaging Type
Vial + Water
Packaging
30ml
Price
₹129/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Cefixime 50mg + Ofloxacin 50mg dry syrup is a broad-spectrum antibiotic combination formulated for the effective treatment of bacterial infections in pediatric and general patients.
This combination works by inhibiting bacterial cell wall synthesis and DNA replication, delivering enhanced antibacterial action against a wide range of gram-positive and gram-negative pathogens.
It is commonly prescribed for respiratory tract infections, gastrointestinal infections, ENT infections, urinary tract infections, and other susceptible bacterial conditions.
With strong clinical acceptance, dual-action efficacy, and suitability for pediatric use, this dry syrup ensures consistent demand and supports portfolio growth in the anti-infective segment.
Common side effects may include nausea, vomiting, diarrhea, abdominal pain, headache, dizziness, or mild skin rash. Most side effects are temporary and resolve on their own.
Indicated for the treatment of gastrointestinal infections, respiratory tract infections, urinary tract infections, typhoid fever, and other mixed bacterial infections caused by susceptible organisms, as prescribed by a healthcare professional.
Use strictly under medical supervision. The full prescribed course should be completed to prevent antibiotic resistance. Not indicated for viral infections. Dosage should be adjusted according to age and body weight.
Store in a cool, dry place below recommended temperature. After reconstitution, use as directed by the physician. Keep out of reach of children.
Composition : Cefpodoxime Proxetil (200mg)
Composition : Cefpodoxime Proxetil (200mg) + Clavulanic Acid (125mg)
Composition : Cefpodoxime Proxetil (200mg) + Ofloxacin (200mg)
Composition : Cefuroxime (250mg)
Composition : Cefuroxime (500mg)
Composition : Cefuroxime (500mg) + Clavulanic Acid (125mg)
Composition : Cephalexin (125mg) DT
Composition : Cephalexin (750mg) ER
Composition : Cephalexin (250mg) DT
Composition : Ciprofloxacin (500mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This pediatric antibiotic combination has strong demand in the anti-infective segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from the consistent demand for this formulation in pediatric bacterial infections, including respiratory tract infections, gastrointestinal infections, and urinary tract infections. It strengthens their pediatric and anti-infective portfolio.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for Cefixime Trihydrate I.P. 50mg + Ofloxacin I.P. 50mg Dry Syrup with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady demand in pediatric care, attractive margins, fast-moving antibiotic segment sales, and consistent market acceptance when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this pediatric antibiotic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk orders, pricing details, and distribution support services.